Endovascular embolisation of external carotid artery system haemorrhage in radiated nasopharyngeal carcinoma

Eur Arch Otorhinolaryngol. 2022 Dec;279(12):5851-5858. doi: 10.1007/s00405-022-07491-8. Epub 2022 Jul 6.

Abstract

Purpose: To review the effectiveness and safety of embolisation in managing haemorrhage from the external carotid artery (ECA) system in radiated nasopharyngeal carcinoma (NPC) patients.

Methods: Radiated NPC patients who presented with severe oronasal bleeding and underwent digital subtraction angiography that excluded blowouts from the internal carotid artery from 2011 to 2021 were reviewed. Those who subsequently underwent embolisation of the ECA system were analysed for technical success rate, post-embolisation re-bleeding rate and complications.

Results: Seventeen embolisations were performed in fifteen patients during the 10-year period. The technical success rate was 100%, however the early haemostatic rate (no re-bleed within 7 days of embolisation) was 70.6% (12/17) and the overall long-term haemostatic rate was 58.8% (10/17). The re-bleed rates of targeted and empiric embolisations were 33.3% (3/9) and 50.0% (4/8), respectively. The re-bleed rates with liquid agents, coils and particles were 0% (0/7), 33.3% (1/3) and 85.7% (6/7), respectively. Amongst the embolisations utilising liquid agents, 71.4% (5/7) were targeted, distal embolisations. All re-bleeds underwent surgical ligation or repeat embolisation; half of them further experienced recurrent bleeding. There were no significant complications with embolisation.

Conclusion: Although embolisation of the ECA system in NPC has a high technical success rate and is safe, re-bleeding appears to be common. Targeted, distal embolisation with liquid embolics appear to have good haemostatic effect. Clinicians should be aware that patients may need repeated procedures to secure haemostasis.

Keywords: Embolisation; External carotid artery; Haemorrhage; Nasopharyngeal cancer.

MeSH terms

  • Carotid Artery, External / diagnostic imaging
  • Embolization, Therapeutic* / adverse effects
  • Embolization, Therapeutic* / methods
  • Hemorrhage / etiology
  • Hemorrhage / therapy
  • Hemostatics*
  • Humans
  • Nasopharyngeal Carcinoma / therapy
  • Nasopharyngeal Neoplasms* / therapy
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Hemostatics